GIP/GLP-1 dual receptor agonist-1

GIP/GLP-1 dual receptor agonist-1 (compound 4) is a GIP/GLP-1 receptor agonist. GIP/GLP-1 dual receptor agonist-1 can be used in the research of metabolic disorders and fatty liver diseases, including nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD)[1].

[1] Brian Lian, et al. Compositions and methods for the treatment of metabolic and liver disorders. WO2022159395.